Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
BioNTech Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for BioNTech Corp from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
05/14/2025 | Buy Now | — | HC Wainwright & Co. | Robert Burns42% | $145 → $134 | Maintains | Buy | Get Alert |
05/06/2025 | Buy Now | — | Citigroup | Geoff Meacham60% | $145 → $140 | Maintains | Buy | Get Alert |
05/06/2025 | Buy Now | — | Morgan Stanley | Terence Flynn63% | $140 → $132 | Maintains | Overweight | Get Alert |
04/01/2025 | Buy Now | — | HC Wainwright & Co. | Robert Burns42% | $150 → $145 | Maintains | Buy | Get Alert |
03/13/2025 | Buy Now | — | Citigroup | Geoff Meacham60% | → $145 | Initiates | → Buy | Get Alert |
03/11/2025 | Buy Now | — | Morgan Stanley | Terence Flynn63% | $145 → $139 | Maintains | Overweight | Get Alert |
03/11/2025 | Buy Now | — | Canaccord Genuity | John Newman43% | $171.44 → $171.44 | Maintains | Buy | Get Alert |
03/11/2025 | Buy Now | — | BMO Capital | Etzer Darout44% | $130 → $143 | Maintains | Outperform | Get Alert |
01/10/2025 | Buy Now | — | Truist Securities | Asthika Goonewardene41% | → $172 | Initiates | → Buy | Get Alert |
12/11/2024 | Buy Now | — | Wells Fargo | Mohit Bansal66% | → $170 | Initiates | → Overweight | Get Alert |
11/27/2024 | Buy Now | — | Canaccord Genuity | William Maughan71% | $171 → $171.44 | Maintains | Buy | Get Alert |
11/26/2024 | Buy Now | — | JP Morgan | Jessica Fye63% | $124 → $122 | Maintains | Neutral | Get Alert |
11/19/2024 | Buy Now | — | Evercore ISI Group | Cory Kasimov67% | $110 → $125 | Upgrade | In-Line → Outperform | Get Alert |
11/18/2024 | Buy Now | — | Canaccord Genuity | John Newman43% | $171 → $171 | Maintains | Buy | Get Alert |
11/18/2024 | Buy Now | — | HC Wainwright & Co. | Robert Burns42% | $150 → $150 | Reiterates | Buy → Buy | Get Alert |
11/14/2024 | Buy Now | — | Canaccord Genuity | John Newman43% | $171 → $171 | Maintains | Buy | Get Alert |
11/08/2024 | Buy Now | — | Goldman Sachs | Chris Shibutani54% | $90 → $137 | Upgrade | Neutral → Buy | Get Alert |
11/06/2024 | Buy Now | — | TD Cowen | Yaron Werber35% | $132 → $122 | Maintains | Hold | Get Alert |
11/05/2024 | Buy Now | — | TD Cowen | Yaron Werber35% | $132 → $122 | Maintains | Hold | Get Alert |
11/04/2024 | Buy Now | — | JP Morgan | Jessica Fye63% | $125 → $124 | Maintains | Neutral | Get Alert |
10/07/2024 | Buy Now | — | HSBC | Yifeng Liu31% | $97 → $136 | Maintains | Buy | Get Alert |
10/07/2024 | Buy Now | — | HC Wainwright & Co. | Robert Burns42% | $113 → $150 | Maintains | Buy | Get Alert |
09/24/2024 | Buy Now | — | Morgan Stanley | Terence Flynn63% | $93 → $145 | Upgrade | Equal-Weight → Overweight | Get Alert |
09/19/2024 | Buy Now | — | Deutsche Bank | Emmanuel Papadakis47% | $95 → $150 | Maintains | Buy | Get Alert |
09/18/2024 | Buy Now | — | UBS | Eliana Merle41% | $97 → $131 | Maintains | Neutral | Get Alert |
09/17/2024 | Buy Now | — | Jefferies | Akash Tewari41% | $96 → $150 | Upgrade | Hold → Buy | Get Alert |
09/16/2024 | Buy Now | — | JP Morgan | Jessica Fye63% | $91 → $125 | Upgrade | Underweight → Neutral | Get Alert |
09/16/2024 | Buy Now | — | B of A Securities | Tazeen Ahmad54% | $125 → $150 | Maintains | Buy | Get Alert |
09/16/2024 | Buy Now | — | HC Wainwright & Co. | Robert Burns42% | $113 → $113 | Reiterates | Buy → Buy | Get Alert |
09/13/2024 | Buy Now | — | Jefferies | Akash Tewari41% | $90 → $96 | Maintains | Hold | Get Alert |
08/27/2024 | Buy Now | — | HC Wainwright & Co. | Robert Burns42% | $113 → $113 | Reiterates | Buy → Buy | Get Alert |
08/19/2024 | Buy Now | — | HC Wainwright & Co. | Robert Burns42% | $113 → $113 | Reiterates | Buy → Buy | Get Alert |
08/15/2024 | Buy Now | — | JP Morgan | Jessica Fye63% | $94 → $91 | Maintains | Underweight | Get Alert |
08/07/2024 | Buy Now | — | Deutsche Bank | Emmanuel Papadakis47% | $95 → $95 | Upgrade | Hold → Buy | Get Alert |
08/06/2024 | Buy Now | — | TD Cowen | Yaron Werber35% | $98 → $85 | Maintains | Hold | Get Alert |
08/01/2024 | Buy Now | — | HC Wainwright & Co. | Robert Burns42% | $113 → $113 | Reiterates | Buy → Buy | Get Alert |
06/26/2024 | Buy Now | — | HC Wainwright & Co. | Robert Burns42% | $113 → $113 | Reiterates | Buy → Buy | Get Alert |
06/12/2024 | Buy Now | — | JP Morgan | Jessica Fye63% | $90 → $94 | Maintains | Underweight | Get Alert |
06/10/2024 | Buy Now | — | HC Wainwright & Co. | Robert Burns42% | $113 → $113 | Reiterates | Buy → Buy | Get Alert |
06/04/2024 | Buy Now | — | HC Wainwright & Co. | Robert Burns42% | $113 → $113 | Reiterates | Buy → Buy | Get Alert |
06/03/2024 | Buy Now | — | HC Wainwright & Co. | Robert Burns42% | $113 → $113 | Reiterates | Buy → Buy | Get Alert |
05/30/2024 | Buy Now | — | HC Wainwright & Co. | Robert Burns42% | $113 → $113 | Reiterates | Buy → Buy | Get Alert |
05/28/2024 | Buy Now | — | HC Wainwright & Co. | Robert Burns42% | $113 → $113 | Reiterates | Buy → Buy | Get Alert |
05/24/2024 | Buy Now | — | HC Wainwright & Co. | Robert Burns42% | $113 → $113 | Reiterates | Buy → Buy | Get Alert |
05/14/2024 | Buy Now | — | Evercore ISI Group | Cory Kasimov67% | → $100 | Initiates | → In-Line | Get Alert |
05/08/2024 | Buy Now | — | HC Wainwright & Co. | Robert Burns42% | $107 → $113 | Maintains | Buy | Get Alert |
05/07/2024 | Buy Now | — | TD Cowen | Yaron Werber35% | $95 → $98 | Maintains | Hold | Get Alert |
05/07/2024 | Buy Now | — | BMO Capital | Etzer Darout44% | $123 → $122 | Maintains | Outperform | Get Alert |
04/17/2024 | Buy Now | — | HC Wainwright & Co. | Robert Burns42% | $107 → $107 | Reiterates | Buy → Buy | Get Alert |
03/27/2024 | Buy Now | — | UBS | Eliana Merle41% | $110 → $101 | Maintains | Neutral | Get Alert |
03/22/2024 | Buy Now | — | JP Morgan | Jessica Fye63% | $99 → $90 | Maintains | Underweight | Get Alert |
03/21/2024 | Buy Now | — | Canaccord Genuity | John Newman43% | $171 → $171 | Reiterates | Buy → Buy | Get Alert |
03/21/2024 | Buy Now | — | BMO Capital | Etzer Darout44% | $127 → $123 | Maintains | Outperform | Get Alert |
02/28/2024 | Buy Now | — | Goldman Sachs | Chris Shibutani54% | $113 → $100 | Maintains | Neutral | Get Alert |
02/23/2024 | Buy Now | — | Canaccord Genuity | John Newman43% | $171 → $171 | Reiterates | Buy → Buy | Get Alert |
02/23/2024 | Buy Now | — | BMO Capital | Etzer Darout44% | → $127 | Initiates | → Outperform | Get Alert |
02/21/2024 | Buy Now | — | Canaccord Genuity | John Newman43% | $171 → $171 | Reiterates | Buy → Buy | Get Alert |
02/20/2024 | Buy Now | — | Canaccord Genuity | John Newman43% | $168 → $171 | Maintains | Buy | Get Alert |
01/23/2024 | Buy Now | — | HC Wainwright & Co. | Robert Burns42% | $133 → $107 | Maintains | Buy | Get Alert |
12/01/2023 | Buy Now | — | JP Morgan | Jessica Fye63% | $106 → $99 | Downgrade | Neutral → Underweight | Get Alert |
11/27/2023 | Buy Now | — | HC Wainwright & Co. | Robert Burns42% | → $133 | Reiterates | Buy → Buy | Get Alert |
11/14/2023 | Buy Now | — | HC Wainwright & Co. | Robert Burns42% | $180 → $133 | Maintains | Buy | Get Alert |
11/08/2023 | Buy Now | — | Morgan Stanley | Matthew Korn45% | $110 → $111 | Maintains | Equal-Weight | Get Alert |
10/17/2023 | Buy Now | — | Morgan Stanley | Matthew Korn45% | $116 → $110 | Maintains | Equal-Weight | Get Alert |
10/16/2023 | Buy Now | — | HSBC | Yifeng Liu31% | $124 → $111 | Downgrade | Buy → Hold | Get Alert |
08/28/2023 | Buy Now | — | HC Wainwright & Co. | Robert Burns42% | → $180 | Reiterates | Buy → Buy | Get Alert |
08/10/2023 | Buy Now | — | HC Wainwright & Co. | Robert Burns42% | $181 → $180 | Maintains | Buy | Get Alert |
08/08/2023 | Buy Now | — | Morgan Stanley | Matthew Korn45% | $119 → $116 | Maintains | Equal-Weight | Get Alert |
08/01/2023 | Buy Now | — | Morgan Stanley | Matthew Korn45% | $119 → $119 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
07/31/2023 | Buy Now | — | Morgan Stanley | Matthew Korn45% | $119 → $119 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
07/24/2023 | Buy Now | — | Morgan Stanley | Matthew Korn45% | $119 → $119 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
07/17/2023 | Buy Now | — | Morgan Stanley | Matthew Korn45% | $119 → $119 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
07/14/2023 | Buy Now | — | HSBC | Rajesh Kumar61% | → $124 | Initiates | → Buy | Get Alert |
07/11/2023 | Buy Now | — | Morgan Stanley | Matthew Korn45% | $124 → $119 | Maintains | Equal-Weight | Get Alert |
06/26/2023 | Buy Now | — | Morgan Stanley | Matthew Korn45% | $124 → $124 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
06/20/2023 | Buy Now | — | Morgan Stanley | Matthew Korn45% | → $124 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
06/16/2023 | Buy Now | — | Canaccord Genuity | John Newman43% | $203 → $203 | Reiterates | Buy → Buy | Get Alert |
06/12/2023 | Buy Now | — | Morgan Stanley | Matthew Korn45% | → $124 | Reiterates | → Equal-Weight | Get Alert |
06/09/2023 | Buy Now | — | HC Wainwright & Co. | Robert Burns42% | → $181 | Reiterates | → Buy | Get Alert |
06/01/2023 | Buy Now | — | HC Wainwright & Co. | Robert Burns42% | $198 → $181 | Maintains | Buy | Get Alert |
05/23/2023 | Buy Now | — | HC Wainwright & Co. | Robert Burns42% | $210 → $198 | Maintains | Buy | Get Alert |
05/18/2023 | Buy Now | — | Deutsche Bank | Emmanuel Papadakis47% | $135 → $120 | Maintains | Hold | Get Alert |
05/17/2023 | Buy Now | — | Redburn Partners | Simon Baker24% | $165 → $170 | Upgrade | Neutral → Buy | Get Alert |
05/09/2023 | Buy Now | — | Morgan Stanley | Matthew Korn45% | $150 → $124 | Maintains | Equal-Weight | Get Alert |
04/24/2023 | Buy Now | — | Deutsche Bank | Emmanuel Papadakis47% | $160 → $135 | Maintains | Hold | Get Alert |
04/10/2023 | Buy Now | — | JP Morgan | Jessica Fye63% | $142 → $128 | Maintains | Neutral | Get Alert |
03/31/2023 | Buy Now | — | UBS | Eliana Merle41% | $168 → $153 | Maintains | Neutral | Get Alert |
03/30/2023 | Buy Now | — | HC Wainwright & Co. | Robert Burns42% | → $210 | Reiterates | → Buy | Get Alert |
03/28/2023 | Buy Now | — | Canaccord Genuity | William Maughan71% | $191 → $203 | Maintains | Buy | Get Alert |
03/28/2023 | Buy Now | — | TD Cowen | Yaron Werber35% | $145 → $130 | Maintains | Market Perform | Get Alert |
03/28/2023 | Buy Now | — | B of A Securities | Tazeen Ahmad54% | $239 → $194 | Maintains | Buy | Get Alert |
03/28/2023 | Buy Now | — | Morgan Stanley | Matthew Korn45% | $216 → $150 | Maintains | Equal-Weight | Get Alert |
03/28/2023 | Buy Now | — | Goldman Sachs | Chris Shibutani54% | $156 → $140 | Maintains | Neutral | Get Alert |
03/23/2023 | Buy Now | — | HC Wainwright & Co. | Robert Burns42% | $272 → $210 | Maintains | Buy | Get Alert |
02/08/2023 | Buy Now | — | JP Morgan | Jessica Fye63% | $148 → $142 | Maintains | Neutral | Get Alert |
01/31/2023 | Buy Now | — | Goldman Sachs | Chris Shibutani54% | $177 → $156 | Maintains | Neutral | Get Alert |
01/24/2023 | Buy Now | — | Morgan Stanley | Matthew Harrison60% | $203 → $216 | Maintains | Equal-Weight | Get Alert |
12/15/2022 | Buy Now | — | B of A Securities | Tazeen Ahmad54% | → $239 | Upgrade | Neutral → Buy | Get Alert |
11/11/2022 | Buy Now | — | Deutsche Bank | Emmanuel Papadakis47% | $180 → $160 | Maintains | Hold | Get Alert |
11/08/2022 | Buy Now | — | Morgan Stanley | Matthew Harrison60% | $194 → $203 | Maintains | Equal-Weight | Get Alert |
The latest price target for BioNTech (NASDAQ:BNTX) was reported by HC Wainwright & Co. on May 14, 2025. The analyst firm set a price target for $134.00 expecting BNTX to rise to within 12 months (a possible 37.01% upside). 44 analyst firms have reported ratings in the last year.
The latest analyst rating for BioNTech (NASDAQ:BNTX) was provided by HC Wainwright & Co., and BioNTech maintained their buy rating.
The last upgrade for BioNTech SE happened on November 19, 2024 when Evercore ISI Group raised their price target to $125. Evercore ISI Group previously had an in-line for BioNTech SE.
The last downgrade for BioNTech SE happened on December 1, 2023 when JP Morgan changed their price target from $106 to $99 for BioNTech SE.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of BioNTech, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for BioNTech was filed on May 14, 2025 so you should expect the next rating to be made available sometime around May 14, 2026.
While ratings are subjective and will change, the latest BioNTech (BNTX) rating was a maintained with a price target of $145.00 to $134.00. The current price BioNTech (BNTX) is trading at is $97.80, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.